Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maynbridge Capital is a specialized investment firm that provides flexible and structured capital solutions to the healthcare and life sciences industries. The firm focuses on middle-market and growth-stage companies across various sub-sectors, including biotechnology, pharmaceuticals, medical technology, and healthcare services. Maynbridge offers a range of financial products such as senior secured debt, royalty-backed financing, and minority equity to support clinical development, commercialization, and strategic acquisitions. Their investment approach is designed to be less dilutive than traditional venture capital, catering to companies with established intellectual property or emerging revenue streams. Headquartered in Greenwich, Connecticut, the firm is led by a team of seasoned professionals with extensive experience in healthcare finance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maynbridge Capital.